Linking physiology to toxicity using DILIsym®, a mechanistic mathematical model of drug‐induced liver injury

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · see citing works

Identification of a nuclear receptor for bile acids

Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714 · see citing works

Concordance of the toxicity of pharmaceuticals in humans and in animals

Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · see citing works

Bile acids: regulation of synthesis

Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,567 · see citing works

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252 · see citing works

Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity

Jaeschke, H., McGill, M. R., & Ramachandran, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.602688 · Cited by 972 · see citing works

Estimating The Cost Of New Drug Development: Is It Really $802 Million?

Adams, C., & Brantner, V. V. (2006) · Health Affairs · doi:10.1377/hlthaff.25.2.420 · Cited by 917 · see citing works

CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses

Chen, G.-Y., Tang, J., Zheng, P., & Liu, Y. (2009) · Science · doi:10.1126/science.1168988 · Cited by 786 · see citing works

Control of respiration and ATP synthesis in mammalian mitochondria and cells

Brown, G. C. (1992) · Biochemical Journal · doi:10.1042/bj2840001 · Cited by 598 · see citing works

Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver

Stieger, B., Fattinger, K. E., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 577 · see citing works

Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions.

Heuman, D. M. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38331-0 · Cited by 555 · see citing works

Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver

Begriche, K., Massart, J., Robin, M., Borgne‐Sanchez, A., & Fromenty, B. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 553 · see citing works

Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity

Jaeschke, H., Williams, C. D., Ramachandran, A., & Bajt, M. L. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02501.x · Cited by 478 · see citing works

A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity

Astashkina, A. I., Mann, B. K., & Grainger, D. W. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.001 · Cited by 432 · see citing works

Deconstructing the Drug Development Process: The New Face of Innovation

Kaitin, K. I. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.293 · Cited by 419 · see citing works

Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity

Russmann, S., Kullak-Ublick, G. A., & Grattagliano, I. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803097 · Cited by 412 · see citing works

Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury

Holt, M. R., Cheng, L., & Ju, C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0308173 · Cited by 398 · see citing works

Bile Acids: The Good, the Bad, and the Ugly

Hofmann, A. F. (1999) · Physiology · doi:10.1152/physiologyonline.1999.14.1.24 · Cited by 376 · see citing works

Organotypic liver culture models: meeting current challenges in toxicity testing

LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363 · see citing works

An Assessment of Statin Safety by Hepatologists

Cohen, D. E., Anania, F. A., & Chalasani, N. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.014 · Cited by 354 · see citing works

The human bile salt export pump: Characterization of substrate specificity and identification of inhibitors

Byrne, J. A., Strautnieks, S. S., Mieli‐Vergani, G., Higgins, C. F., Linton, K. J., & Thompson, R. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36591 · Cited by 337 · see citing works

Physiologically Based Pharmacokinetics Joined with In Vitro–In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology

Rostami-Hodjegan, A. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.65 · Cited by 331 · see citing works

The origin, kinetics, and characteristics of the kupffer cells in the normal steady state

Crofton, R. W., Dulk, M. D.-D., & van Furth, R. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.1.1 · Cited by 322 · see citing works

The enterohepatic circulation of bile acids in mammals: form and functions

Alan, F. (2009) · Frontiers in bioscience · doi:10.2741/3399 · Cited by 321 · see citing works

In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans

Dawson, S., Stahl, S. H., Paul, N. R., Barber, J., & Kenna, J. G. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040758 · Cited by 321 · see citing works

Protection against acetaminophen-induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase

Bourdi, M., Masubuchi, Y., Reilly, T. P., Amouzadeh, H. R., Martin, J. L., George, J. W., Shah, A. G., & Pohl, L. R. (2002) · Hepatology · doi:10.1053/jhep.2002.30956 · Cited by 304 · see citing works

Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms

Gould, G. W., THOMAS, H. M., Jess, T. J., & Bell, G. I. (1991) · Biochemistry · doi:10.1021/bi00235a004 · Cited by 303 · see citing works

Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses

Teff, K. L., Grudziak, J., Townsend, R. R., Dunn, T. N., Grant, R. W., Adams, S. H., Keim, N. L., Cummings, B. P., Stanhope, K. L., & Havel, P. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2192 · Cited by 301 · see citing works

In silico toxicology for the pharmaceutical sciences☆

Valerio, L. G. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.022 · Cited by 297 · see citing works

Hepatic Transport of Bile Salts

Kullak-Ublick, G. A., Stieger, B., Hagenbuch, B., & Meier, P. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9426 · Cited by 292 · see citing works

A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study

Holubarsch, C., Rohrbach, M., Karrasch, M., Boehm, E., Poloński, L., Ponikowski, P. P., & Rhein, S. (2007) · Clinical Science · doi:10.1042/cs20060307 · Cited by 289 · see citing works

The future of drug safety testing: expanding the view and narrowing the focus

Stevens, J. L., & Baker, T. K. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.11.009 · Cited by 286 · see citing works

Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids

Attili, A. F., Angelico, M., Cantàfora, A., Alvaro, D., & Capocaccia, L. (1986) · Medical Hypotheses · doi:10.1016/0306-9877(86)90137-4 · Cited by 277 · see citing works

The State of Innovation in Drug Development

Kola, I. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100479 · Cited by 276 · see citing works

The Role of the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) and of the Bile Salt Export Pump (BSEP) in Physiology and Pathophysiology of Bile Formation

Stieger, B. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_5 · Cited by 268 · see citing works

Detoxification of Lithocholic Acid, A Toxic Bile Acid: Relevance to Drug Hepatotoxicity

Hofmann, A. F. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033475 · Cited by 268 · see citing works

Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism

Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260 · see citing works

Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase.

Falany, C. N., Johnson, M. R., Barnes, S., & Diasio, R. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32178-6 · Cited by 250 · see citing works

Influence of Oral Glucose Ingestion on Splanchnic Glucose and Gluconeogenic Substrate Metabolism in Man

Felig, P., Wahren, J., & Hendler, R. (1975) · Diabetes · doi:10.2337/diab.24.5.468 · Cited by 228 · see citing works

Predicting Drug-Induced Hepatotoxicity Using QSAR and Toxicogenomics Approaches

Low, Y., Uehara, T., Minowa, Y., Yamada, H., Ohno, Y., Urushidani, T., Sedykh, A., Muratov, E. N., Кузьмин, В. Е., Fourches, D., et al. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200148a · Cited by 224 · see citing works

High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo

Antoine, D. J., Williams, D. P., Kipar, A., Jenkins, R. E., Regan, S. L., Sathish, J. G., Kitteringham, N. R., & Park, B. K. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp235 · Cited by 223 · see citing works

Drug Safety Sciences and the Bottleneck in Drug Development

Watkins, P. B. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.63 · Cited by 211 · see citing works

Mitochondrially-mediated toxicity of bile acids

Palmeira, C. M., & Rolo, A. P. (2004) · Toxicology · doi:10.1016/j.tox.2004.06.001 · Cited by 207 · see citing works

In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone

Dykens, J. A., Jamieson, J. D., Marroquin, L. D., Nadanaciva, S., Xu, J. J., Dunn, M. C., Smith, A. R., & Will, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn056 · Cited by 195 · see citing works

Bile Acids Affect Liver Mitochondrial Bioenergetics: Possible Relevance for Cholestasis Therapy

Rolo, A. P. (2000) · Toxicological Sciences · doi:10.1093/toxsci/57.1.177 · Cited by 182 · see citing works

Prediction of Liver Injury Induced by Chemicals in Human With a Multiparametric Assay on Isolated Mouse Liver Mitochondria

Porceddu, M., Buron, N., Roussel, C., Labbe, G., Fromenty, B., & Borgne‐Sanchez, A. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs197 · Cited by 180 · see citing works

Regulation of bile acid synthesis. III. Correlation between biliary bile salt hydrophobicity index and the activities of enzymes regulating cholesterol and bile acid synthesis in the rat.

Heuman, D. M., Hylemon, P. B., & Vlahcevic, Z. R. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38276-6 · Cited by 163 · see citing works

Dose-Response of Five Bile Acids on Serum and Liver Bile Acid Concentrations and Hepatotoxicty in Mice

Song, P., Zhang, Y., & Klaassen, C. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr177 · Cited by 155 · see citing works

A High-Fat Diet Impairs Liver Regeneration in C57BL/6 Mice Through Overexpression of the NF-κB Inhibitor, IκBα * #

DeAngelis, R. A., Markiewski, M. M., Taub, R. A., & Lambris, J. D. (2005) · Hepatology · doi:10.1002/hep.20879 · Cited by 152 · see citing works

ATP depletion rather than mitochondrial depolarization mediates hepatocyte killing after metabolic inhibition

Nieminen, A. L., Saylor, A. K., Herman, B., & Lemasters, J. J. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.1.c67 · Cited by 151 · see citing works

Potential role of activated macrophages in acetaminophen hepatotoxicity

Laskin, D. L., Pilaro, A. M., & Ji, S. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90052-9 · Cited by 139 · see citing works

In silico models for the prediction of dose-dependent human hepatotoxicity

Cheng, A., & Dixon, S. L. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/b:jcam.0000021834.50768.c6 · Cited by 126 · see citing works

Differential Expression of Mouse Hepatic Transporter Genes in Response to Acetaminophen and Carbon Tetrachloride

Aleksunes, L. M., Slitt, A. L., Cherrington, N. J., Thibodeau, M. S., Klaassen, C. D., & Manautou, J. E. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi013 · Cited by 125 · see citing works

A Predictive Ligand-Based Bayesian Model for Human Drug-Induced Liver Injury

Ekins, S., Williams, A. J., & Xu, J. J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035113 · Cited by 122 · see citing works

Distribution of blood monocytes between a marginating and a circulating pool.

van Furth, R., & Sluiter, W. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.2.474 · Cited by 119 · see citing works

Control of oxidative phosphorylation in rat muscle mitochondria: implications for mitochondrial myopathies

Letellier, T., Malgat, M., & Mazat, J. (1993) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(93)90189-m · Cited by 118 · see citing works

Interleukin-11 Links Oxidative Stress and Compensatory Proliferation

Nishina, T., Komazawa‐Sakon, S., Yanaka, S., Piao, X., Zheng, D.-M., Piao, J., Kojima, Y., Yamashina, S., Sano, E., Putoczki, T. L., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002056 · Cited by 115 · see citing works

Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies

Dixit, R., & Boelsterli, U. A. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.02.018 · Cited by 112 · see citing works

The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells

Zahno, A., Brecht, K., Morand, R., Maseneni, S., Török, M., Lindinger, P. W., & Krähenbühl, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.002 · Cited by 109 · see citing works

Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism

Gandelman, K., Zhu, T., Fahmi, O. A., Glue, P., Lian, K., Obach, R. S., & Damle, B. D. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010366445 · Cited by 109 · see citing works

Sinusoidal endothelial cells as a target for acetaminophen toxicity

DeLeve, L. D., Wang, X., Kaplowitz, N., Shulman, H. M., Bart, J. A., & Hoek, A. V. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00048-8 · Cited by 108 · see citing works

The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice

Ishida, Y., Kondo, T., Tsuneyama, K., Lu, P., Takayasu, T., & Mukaida, N. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403152 · Cited by 108 · see citing works

Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate: A comparison of human BSEP with rat Bsep

Hayashi, H., Takada, T., Suzuki, H., Onuki, R., Hofmann, A. F., & Sugiyama, Y. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.10.006 · Cited by 107 · see citing works

The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man

Ferrannini, E., Wahren, J., Felig, P., & DeFronzo, R. A. (1980) · Metabolism · doi:10.1016/0026-0495(80)90094-3 · Cited by 106 · see citing works

In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI

Howell, B. A., Yang, Y., Kumar, R., Woodhead, J. L., Harrill, A. H., M.A., H. J. C. I., Andersen, M. E., Siler, S. Q., & Watkins, P. B. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9266-0 · Cited by 105 · see citing works

Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate.

Yamamoto, T., Naito, M., Moriyama, H., Umezu, H., Matsuo, H., Kiwada, H., & Arakawa, M. (1996) · Europe PMC (PubMed Central) · Cited by 103 · see citing works

Acetaminophen‐related acute liver failure in the United States

Lee, W. M. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00419.x · Cited by 102 · see citing works

Characterization of the Mouse Bile Salt Export Pump Overexpressed in the Baculovirus System

Noé, J., Hagenbuch, B., Meier, P. J., & St–Pierre, M. V. (2001) · Hepatology · doi:10.1053/jhep.2001.24171 · Cited by 99 · see citing works

Proton electrochemical gradient and phosphate potential in mitochondria

AZZONE, G. F., Pozzan, T., & Massari, S. (1978) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(78)90036-1 · Cited by 94 · see citing works

Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans.

Capaldo, B., Gastaldelli, A., Antoniello, S., Auletta, M., Pardo, F., Ciociaro, D., Guida, R., Ferrannini, E., & Saccà, L. (1999) · Diabetes · doi:10.2337/diabetes.48.5.958 · Cited by 94 · see citing works

Effect of Membrane Cholesterol on BSEP/Bsep Activity: Species Specificity Studies for Substrates and Inhibitors

Kis, E., Ioja, E., Nagy, T., Szente, L., Herédi‐Szabó, K., & Krajcsi, P. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024778 · Cited by 93 · see citing works

Citrate and the regulation of adipose-tissue phosphofructokinase

Denton, R., & Pj, R. (1966) · Biochemical Journal · doi:10.1042/bj1000420 · Cited by 89 · see citing works

Competitive inhibition of liver glucokinase by its regulatory protein

Vandercammen, A., & SCHAFTINGEN, E. V. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16217.x · Cited by 89 · see citing works

Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform

Nadanaciva, S., Rana, P., Beeson, G. C., Chen, D., Ferrick, D. A., Beeson, C. C., & Will, Y. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9446-z · Cited by 87 · see citing works

In silicomodels for drug-induced liver injury – current status

Przybylak, K. R., & Cronin, M. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.648613 · Cited by 82 · see citing works

Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury.

Bourdi, M., Eiras, D., Holt, M. P., Webster, M. R., Reilly, T., Welch, K., & Pohl, L. (2007) · Chemical Research in Toxicology · doi:10.1021/tx060228l · Cited by 80 · see citing works

Acquired Resistance to Acetaminophen Hepatotoxicity is Associated with Induction of Multidrug Resistance-Associated Protein 4 (Mrp4) in Proliferating Hepatocytes

Aleksunes, L. M., Campion, S. N., Goedken, M. J., & Manautou, J. E. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn093 · Cited by 80 · see citing works

An Analysis of N-Acetylcysteine Treatment for Acetaminophen Overdose Using a Systems Model of Drug-Induced Liver Injury

Woodhead, J. L., Howell, B. A., Yang, Y., Harrill, A. H., M.A., H. J. C. I., Andersen, M. E., Siler, S. Q., & Watkins, P. B. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192930 · Cited by 78 · see citing works

Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt

Mullen, P. J., Zahno, A., Lindinger, P. W., Maseneni, S., Felser, A., Krähenbühl, S., & Brecht, K. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.07.019 · Cited by 76 · see citing works

Macrophage activation by factors released from acetaminophen-injured hepatocytes: Potential role of HMGB1

Dragomir, A.-C., Laskin, J. D., & Laskin, D. L. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.04.003 · Cited by 76 · see citing works

Cell based approaches for evaluation of drug-induced liver injury

Greer, M. L., Barber, J., Eakins, J. A., & Kenna, J. G. (2009) · Toxicology · doi:10.1016/j.tox.2009.08.007 · Cited by 73 · see citing works

Role of immune reactions in drug-induced liver injury (DILI)

Ju, C., & Reilly, T. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.645579 · Cited by 73 · see citing works

Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: Early discrimination between survival and death

Remien, C. H., Adler, F. R., Waddoups, L. J., Box, T. D., & Sussman, N. (2012) · Hepatology · doi:10.1002/hep.25656 · Cited by 72 · see citing works

Bacterial- and Viral-Induced Inflammation Increases Sensitivity to Acetaminophen Hepatotoxicity

Maddox, J. F., Amuzie, C. J., Li, M., Newport, S. W., Sparkenbaugh, E., Cuff, C. F., Pestka, J. J., Cantor, G. H., Roth, R. A., & Ganey, P. E. (2009) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390903249057 · Cited by 71 · see citing works

Dinitrophenol-induced mitochondrial uncoupling in vivo triggers respiratory adaptation in HepG2 cells

Desquiret‐Dumas, V., Loiseau, D., Jacques, C., Douay, O., Malthièry, Y., Ritz, P., & Roussel, D. (2005) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2005.11.005 · Cited by 69 · see citing works

Hepatoprotective Role of Endogenous Interleukin-13 in a Murine Model of Acetaminophen-Induced Liver Disease

Yee, S. B., Bourdi, M., Masson, M. J., & Pohl, L. R. (2007) · Chemical Research in Toxicology · doi:10.1021/tx600349f · Cited by 68 · see citing works

Local Proliferation and Extrahepatic Recruitment of Liver Macrophages (Kupffer Cells) in Partial-Body Irradiated Rats

Bouwens, L., Knook, D. L., & Wisse, E. (1986) · Journal of Leukocyte Biology · doi:10.1002/jlb.39.6.687 · Cited by 68 · see citing works

Acetaminophen-induced hepatotoxicity is associated with early changes in NF-kB and NF-IL6 DNA binding activity.

Blazka, M. E., Dr, G., Simeonova, P. P., Bruccoleri, A., Pennypacker, K. R., & Luster, M. I. (1995) · PubMed · Cited by 67 · see citing works

Modeling Drug- and Chemical-Induced Hepatotoxicity with Systems Biology Approaches

Bhattacharya, S., Shoda, L. K. M., Zhang, Q., Woods, C. G., Howell, B. A., Siler, S. Q., Woodhead, J. L., Yang, Y., McMullen, P. D., Watkins, P. B., et al. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00462 · Cited by 64 · see citing works

High mobility group B1 impairs hepatocyte regeneration in acetaminophen hepatotoxicity

Yang, R., Zhang, S., Cotoia, A., Oksala, N., Zhu, S., & Tenhunen, J. J. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-45 · Cited by 63 · see citing works

Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration

Hue, L., Sobrino, F., & Boscá, L. (1984) · Biochemical Journal · doi:10.1042/bj2240779 · Cited by 61 · see citing works

Impact of microdosing clinical study — Why necessary and how useful?

Sugiyama, Y., & Yamashita, S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.010 · Cited by 60 · see citing works

Continuous monitoring of mitochondrial membrane potential in hepatocyte cell suspensions

Palmeira, C. M., Moreno, A. J., Madeira, V. M. C., & Wallace, K. B. (1996) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/1056-8719(95)00131-x · Cited by 58 · see citing works

Tumour Necrosis Factor Receptor 1 and Hepatocyte Regeneration in Acetaminophen Toxicity: A Kinetic Study of Proliferating Cell Nuclear Antigen and Cytokine Expression

James, L. P., Kurten, R. C., Lamps, L. W., McCullough, S. S., & Hinson, J. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_97102.x · Cited by 55 · see citing works

Internal regulation of ATP turnover, glycolysis and oxidative phosphorylation in rat hepatocytes

Ainscow, E., & Brand, M. D. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00856.x · Cited by 53 · see citing works

Cutting Edge PBPK Models and Analyses: Providing the Basis for Future Modeling Efforts and Bridges to Emerging Toxicology Paradigms

Caldwell, J. C., Evans, M. V., & Krishnan, K. (2012) · Journal of Toxicology · doi:10.1155/2012/852384 · Cited by 51 · see citing works

HMGB1 and Microparticles as Mediators of the Immune Response to Cell Death

Pisetsky, D. S., Gauley, J., & Ullal, A. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3865 · Cited by 50 · see citing works

Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices

Vickers, A. E. M., Bentley, P., & Fisher, R. L. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.01.021 · Cited by 48 · see citing works

Disposition of a mixed meal by the conscious dog

Moore, M. C., Pagliassotti, M. J., Swift, L. L., Asher, J. R., Murrell, J. E., Neal, D. W., & Cherrington, A. D. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.4.e666 · Cited by 47 · see citing works

Glyburide-Induced Hepatitis

GOODMAN, R. C., DEAN, P. J., RADPARVAR, A., & KITABCHI, A. E. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-837 · Cited by 45 · see citing works

A review of the use ofin silicomethods to predict the chemistry of molecular initiating events related to drug toxicity

Ellison, C. M., Enoch, S. J., & Cronin, M. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.629186 · Cited by 35 · see citing works

Impact and prevalence of safety pharmacology-related toxicities throughout the pharmaceutical life cycle

Redfern, W. S., Bialecki, R., Ewart, L. C., Hammond, T. G., Kinter, L. D., Lindgren, S., Pollard, C. E., Rolf, M. G., & Valentin, J. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.11.098 · Cited by 34 · see citing works

Control analysis of mitochondrial metabolism in intact hepatocytes: effect of interleukin-1β and interleukin-6

Francois Berthiaume, B., MacDonald, A. D., Kang, Y. H., & Yarmush, M. L. (2003) · Metabolic Engineering · doi:10.1016/s1096-7176(03)00010-7 · Cited by 33 · see citing works

Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury

Mathew, J. P., Hines, J. E., James, O., & Burt, A. D. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80502-1 · Cited by 32 · see citing works

Current Concepts in Drug‐Induced Mitochondrial Toxicity

Nadanaciva, S., & Will, Y. (2009) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx0215s40 · Cited by 31 · see citing works

Prevention of acetaminophen-induced liver toxicity by 2(R,S)-n-propylthiazolidine-4(R)-carboxylic acid in mice

Srinivasan, C., Williams, W. M., Ray, M. B., & Chen, T. S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00558-x · Cited by 31 · see citing works

Interactions of combined bile acids on hepatocyte viability: cytoprotection or synergism

Rolo, A. P., Palmeira, C. M., & Wallace, K. B. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00464-7 · Cited by 26 · see citing works

Differences between human, rat and guinea pig hepatocyte cultures

Agius, L., Peak, M., & Sherratt, H. S. A. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90506-z · Cited by 24 · see citing works

Effects of monocrotaline on energy metabolism in the rat liver

Mingatto, F. E., Maioli, M. A., Bracht, A., & Ishii‐Iwamoto, E. L. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.09.004 · Cited by 24 · see citing works

Analysis of the synergistic stimulation of mouse macrophage proliferation by macrophage colony-stimulating factor (CSF-1) and tumor necrosis factor a (TNF-α)

Guilbert, L. J., Winkler‐Lowen, B., Smith, A., Branch, D. R., & Garcia-Lloret, M. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.1.65 · Cited by 23 · see citing works

A Semiphysiologically Based Pharmacokinetic Modeling Approach to Predict the Dose-Exposure Relationship of an Antiparasitic Prodrug/Active Metabolite Pair

Yan, G. Z., Generaux, C., Yoon, M., Goldsmith, R. B., Tidwell, R. R., Hall, J. E., Olson, C. A., M.A., H. J. C. I., Brouwer, K. L. R., & Paine, M. F. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040063 · Cited by 23 · see citing works

Evaluation of Human Interindividual Variation in Bioactivation of Estragole Using Physiologically Based Biokinetic Modeling

Punt, A., Jeurissen, S. M. F., Boersma, M. G., Delatour, T., Scholz, G., Schilter, B., van BLADEREN, P. J., & Rietjens, I. M. C. M. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp272 · Cited by 22 · see citing works

Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.

van Basten, J. P., van Hoek, B., Zeijen, R. N. M., & Stockbrügger, R. W. (1992) · PubMed · Cited by 19 · see citing works

The effects of the inhibition of fatty acid oxidation on pyruvate dehydrogenase complex activity in tissues of lean and obese mice.

Bryson, J. M., Cooney, G. J., Wensley, V. R., Phuyal, J. L., & Caterson, I. D. (1996) · PubMed · Cited by 18 · see citing works

Circadian Changes in Serum and Liver Metabolites and Liver Lipogenic Enzymes in Ad Libitum- and Meal-Fed, Lean and Obese Zucker Rats

Lanza‐Jacoby, S., Stevenson, N. R., & Kaplan, M. L. (1986) · Journal of Nutrition · doi:10.1093/jn/116.9.1798 · Cited by 18 · see citing works

Induction of a hepatic toxic syndrome in the Dutch-belted rabbit by a quinoxalinone anxiolytic

Rg, U. (1995) · Toxicology · doi:10.1016/0300-483x(94)02951-p · Cited by 17 · see citing works

Cell kinetic analysis of a murine macrophage cell line.

van Furth, R., Elzenga-Claasen, I., van Schadewijk-Nieuwstad, M., Dulk, M. M. C. D.-D., Toivonen, H., & Rytömaa, T. (1987) · PubMed · Cited by 12 · see citing works

Increased ATP inhibition of liver phosphofructokinase from genetically diabetic mice.

Hosey, M. M., Chatterjee, T., Cohen, A. J., Stein, A. L., Kemp, R. G., & Marcus, G. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2497 · Cited by 12 · see citing works

Deletion of protein kinase Cε in mice has limited effects on liver metabolite levels but alters fasting ketogenesis and gluconeogenesis

Raddatz, K., Frangioudakis, G., Diakanastasis, B., Liao, B. M., Leitges, M., & Schmitz‐Peiffer, C. (2012) · Diabetologia · doi:10.1007/s00125-012-2647-5 · Cited by 10 · see citing works

Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective

Kenna, J. G., Taskar, K. S., Battista, C., Bourdet, D. L., Brouwer, K. L. R., Brouwer, K. R., Dai, D., Funk, C., Hafey, M. J., Lai, Y., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1222 · Cited by 124 · see citing works

Microengineered Liver Tissues for Drug Testing

Khetani, S. R., Berger, D. R., Ballinger, K. R., Davidson, M. D., Lin, C., & Ware, B. R. (2015) · SLAS Technology · doi:10.1177/2211068214566939 · Cited by 116 · see citing works

Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid–Mediated Troglitazone Hepatotoxicity

Yang, K., Woodhead, J. L., Watkins, P. B., Howell, B. A., & Brouwer, K. L. R. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.158 · Cited by 95 · see citing works

Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury

Woodhead, J. L., Yang, K., Siler, S. Q., Watkins, P. B., Brouwer, K. L. R., Barton, H. A., & Howell, B. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00240 · Cited by 93 · see citing works

Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors

Woodhead, J. L., Brock, W. J., Roth, S. E., Shoaf, S. E., Brouwer, K. L. R., Church, R. J., Grammatopoulos, T. N., Stiles, L., Siler, S. Q., Howell, B. A., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw193 · Cited by 92 · see citing works

A model qualification method for mechanistic physiological QSP models to support model‐informed drug development

Friedrich, C. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12056 · Cited by 87 · see citing works

Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury

Yang, K., Guo, C., Woodhead, J. L., Claire, R. L. S., Watkins, P. B., Siler, S. Q., Howell, B. A., & Brouwer, K. L. R. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.008 · Cited by 86 · see citing works

Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym ® , a Mechanistic Model of Drug‐Induced Liver Injury

Longo, D., Yang, Y., Watkins, P. B., Howell, B. A., & Siler, S. (2016) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12053 · Cited by 73 · see citing works

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction

Segovia‐Zafra, A., Zeo-Sánchez, D. E. D., Gomez, C. L., Pérez-Valdés, Z., García‐Fuentes, E., Andrade, R. J., Lucena, M. I., & Paz, M. V. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 71 · see citing works

Application of new approach methodologies for nonclinical safety assessment of drug candidates

Beilmann, M., Adkins, K., Boonen, H. C. M., Hewitt, P. G., Hu, W., Mader, R., Moore, S., Rana, P., Steger‐Hartmann, T., Villenave, R., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01182-9 · Cited by 70 · see citing works

Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling

Woodhead, J. L., Yang, K., Oldach, D., MacLauchlin, C., FERNANDES, P. B., Watkins, P. B., Siler, S. Q., & Howell, B. A. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2582-y · Cited by 65 · see citing works

Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury

Lin, C., & Khetani, S. R. (2016) · BioMed Research International · doi:10.1155/2016/1829148 · Cited by 55 · see citing works

The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation

Watkins, P. B. (2019) · Clinical and Translational Science · doi:10.1111/cts.12629 · Cited by 60 · see citing works

Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities

Kirouac, D. C., Cicali, B., & Schmidt, S. (2019) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12390 · Cited by 46 · see citing works

Key to Opening Kidney for In Vitro–In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data

Scotcher, D., Jones, C. R., Posada, M. M., Rostami‐Hodjegan, A., & Galetin, A. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9942-x · Cited by 49 · see citing works

Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

Sové, R. J., Verma, B. K., Wang, H., Ho, W. J., Yarchoan, M. M., & Popel, A. S. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005414 · Cited by 49 · see citing works

The application of engineered liver tissues for novel drug discovery

Lin, C., Ballinger, K. R., & Khetani, S. R. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1032241 · Cited by 43 · see citing works

Quantitative Systems Toxicology Analysis ofIn VitroMechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury

Longo, D., Woodhead, J. L., Walker, P., Herédi‐Szabó, K., Mogyorósi, K., Wolenski, F. S., Dragan, Y. P., Mosedale, M., Siler, S. Q., Watkins, P. B., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy253 · Cited by 43 · see citing works

Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: contrasts with BMS-986234 and BMS-986278

Gill, M. W., Murphy, B. J., Cheng, P. T. W., Sivaraman, L., Davis, M., & Lehman-McKeeman, L. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115885 · Cited by 41 · see citing works

MITOsym®: A Mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics

Yang, Y., Nadanaciva, S., Will, Y., Woodhead, J. L., Howell, B. A., Watkins, P. B., & Siler, S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1591-0 · Cited by 41 · see citing works

Systems pharmacology modeling of drug‐induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transporters

Yang, K., Battista, C., Woodhead, J., Stahl, S. H., Mettetal, J. T., Watkins, P. B., Siler, S., & Howell, B. A. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.619 · Cited by 39 · see citing works

The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development

Sistare, F. D., Mattes, W. B., & LeCluyse, E. L. (2016) · ILAR Journal · doi:10.1093/ilar/ilw025 · Cited by 39 · see citing works

Liver toxicity of macrolide antibiotics in zebrafish

Zhang, M., Chen, B., Zhang, J., Chen, N., Liu, C., & Chang-qin, H. (2020) · Toxicology · doi:10.1016/j.tox.2020.152501 · Cited by 39 · see citing works

Use of a systems model of drug-induced liver injury (DILIsym®) to elucidate the mechanistic differences between acetaminophen and its less-toxic isomer, AMAP, in mice

Howell, B. A., Siler, S. Q., & Watkins, P. B. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.02.007 · Cited by 37 · see citing works

Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials

Longo, D., Generaux, G., Howell, B. A., Siler, S., Antoine, D., Button, D. C., Caggiano, A., Eisen, A., Iaci, J. F., Stanulis, R., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.711 · Cited by 37 · see citing works

Mechanistic Systems Modeling to Improve Understanding and Prediction of Cardiotoxicity Caused by Targeted Cancer Therapeutics

Shim, J. V., Chun, B., van Hasselt, J. G. C., Birtwistle, M. R., Saucerman, J. J., & Sobie, E. A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00651 · Cited by 32 · see citing works

Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology Modeling

Woodhead, J. L., Pellegrini, L., Shoda, L. K. M., & Howell, B. A. (2020) · Pharmaceutical Research · doi:10.1007/s11095-019-2726-0 · Cited by 32 · see citing works

Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses

Shoda, L. K. M., Battista, C., Siler, S. Q., Pisetsky, D. S., Watkins, P. B., & Howell, B. A. (2017) · Gene Regulation and Systems Biology · doi:10.1177/1177625017696074 · Cited by 31 · see citing works

Systems pharmacology to predict drug safety in drug development

Trame, M. N., Biliouris, K., Lesko, L. J., & Mettetal, J. T. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.027 · Cited by 30 · see citing works

Quantitative Systems Toxicology Approaches to Understand and Predict Drug-Induced Liver Injury

Watkins, P. B. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.09.003 · Cited by 30 · see citing works

Current insights in the complexities underlying drug-induced cholestasis

Deferm, N., Vocht, T. D., Qi, B., Brantegem, P. V., Gijbels, E., Vinken, M., de Witte, P. A. M., Bouillon, T. W., & Annaert, P. (2019) · Critical Reviews in Toxicology · doi:10.1080/10408444.2019.1635081 · Cited by 24 · see citing works

DILIsym: Quantitative systems toxicology impacting drug development

Watkins, P. B. (2020) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2020.06.003 · Cited by 24 · see citing works

Applications of In Silico Models to Predict Drug-Induced Liver Injury

Lin, J., Li, M., Mak, W. Y., Shi, Y., Zhu, X., Tang, Z., He, Q., & Xiang, X. (2022) · Toxics · doi:10.3390/toxics10120788 · Cited by 24 · see citing works

Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen

Eichenbaum, G. M., Yang, K., Gebremichael, Y., Howell, B. A., Murray, F. J., Jacobson‐Kram, D., Jaeschke, H., Kuffner, E. K., Gelotte, C. K., Lai, J. C. K., et al. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104788 · Cited by 23 · see citing works

The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development

Zhou, Z., Zhu, J., Jiang, M., Sang, L., Hao, K., & He, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050704 · Cited by 22 · see citing works

Quantitative systems toxicology (QST) reproduces species differences in PF‐04895162 liver safety due to combined mitochondrial and bile acid toxicity

Generaux, G. T., Lakhani, V., Yang, Y., Nadanaciva, S., Qiu, L., Riccardi, K. A., Di, L., Howell, B. A., Siler, S. Q., Watkins, P. B., et al. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.523 · Cited by 22 · see citing works

Assessing Liver Effects of Cannabidiol and Valproate Alone and in Combination Using Quantitative Systems Toxicology

Lakhani, V., Generaux, G. T., Howell, B. A., Longo, D., & Watkins, P. B. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3004 · Cited by 21 · see citing works

Mechanism-based integrated assay systems for the prediction of drug-induced liver injury

Kawaguchi, M., Nukaga, T., Sekine, S., Takemura, A., Susukida, T., Oeda, S., Kodama, A., Hirota, M., Kouzuki, H., & Ito, K. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114958 · Cited by 19 · see citing works

Endeavours made by trade associations, pharmaceutical companies and regulators in the replacement, reduction and refinement of animal experimentation in safety testing of pharmaceuticals

Harrell, A. W., Reid, K., Vahle, J. L., Brouta, F., Beilmann, M., Young, G. C., Beattie, K. A., Valentin, J. P., Shaid, S., & Brinck, P. R. (2024) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2024.105683 · Cited by 18 · see citing works

Quantitative systems toxicology modeling in pharmaceutical research and development: An industry‐wide survey and selected case study examples

Beattie, K. A., Verma, M., Brennan, R., Clausznitzer, D., Damian, V., Leishman, D. J., Spilker, M. E., Boras, B. W., Li, Z., Oziolor, E. M., et al. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13227 · Cited by 17 · see citing works

Development of quantitative systems pharmacology and toxicology models within consortia: experiences and lessons learned through DILIsym development

Howell, B. A., Siler, S. Q., Barton, H. A., Joshi, E., Cabal, A., Eichenbaum, G. M., & Watkins, P. B. (2016) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2017.04.001 · Cited by 17 · see citing works

Latest advances in diagnosing and predicting DILI: what was new in 2017?

Barnhill, M. S., Real, M., & Lewis, J. H. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1512854 · Cited by 17 · see citing works

Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym

Longo, D., Shoda, L. K. M., Howell, B. A., Coric, V., Berman, R., & Qureshi, I. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa019 · Cited by 16 · see citing works

Virtual Systems Pharmacology (ViSP) software for simulation from mechanistic systems-level models

Ermakov, S., Forster, P., Pagidala, J., Miladinov, M., Wang, A., Baillie, R., Bartlett, D. W., Reed, M., & Leil, T. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00232 · Cited by 15 · see citing works

Assessment of liver injury potential of investigational medicines in drug development

Chalasani, N., Hayashi, P. H., Luffer, D. R., Regev, A., & Watkins, P. B. (2025) · Hepatology · doi:10.1097/hep.0000000000001281 · Cited by 14 · see citing works

Using Quantitative Systems Toxicology to Investigate Observed Species Differences in CKA-Mediated Hepatotoxicity

Battista, C., Yang, K., Stahl, S. H., Mettetal, J. T., Watkins, P. B., Siler, S. Q., & Howell, B. A. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy191 · Cited by 14 · see citing works

Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition

Beaudoin, J. J., Yang, K., Adiwidjaja, J., Taneja, G., Watkins, P. B., Siler, S. Q., Howell, B. A., & Woodhead, J. L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1085621 · Cited by 11 · see citing works

Application of Systems Pharmacology to Explore Mechanisms of Hepatotoxicity

SHON, J., & Abernethy, D. R. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.167 · Cited by 11 · see citing works

A Rapid Method to Estimate Hepatocyte Loss Due to Drug‐Induced Liver Injury

Chung, J., Longo, D., & Watkins, P. B. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1254 · Cited by 11 · see citing works

Quantitative Systems Toxicology Identifies Independent Mechanisms for Hepatotoxicity and Bilirubin Elevations Due to AKR1C3 Inhibitor BAY1128688

Battista, C., Shoda, L. K. M., Watkins, P. B., Groettrup‐Wolfers, E., Rottmann, A., Raschke, M., & Generaux, G. T. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3010 · Cited by 10 · see citing works

Quantitative Systems Pharmacology: Applications and Adoption in Drug Development

Ramanujan, S., Gadkar, K. G., & Kadambi, A. (2016) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-44534-2_3 · Cited by 10 · see citing works

Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application

Siler, S. Q. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03295-x · Cited by 10 · see citing works

Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet

Lucena, M., Paz, M. V., Alvarez-Alvarez, I., Aithal, G. P., Björnsson, E. S., Cakan‐Akdogan, G., Cubero, F. J., Esteves, F., Falcón‐Pérez, J. M., Fromenty, B., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107046 · Cited by 9 · see citing works

Liver safety evaluation of endothelin receptor antagonists using HepatoPac®: A single model impact assessment on hepatocellular health, function and bile acid disposition

Aleo, M. D., Ukairo, O. T., Moore, A., Irrechukwu, O., Potter, D. M., & Schneider, R. P. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3805 · Cited by 9 · see citing works

Human biology-based drug safety evaluation: scientific rationale, current status and future challenges

Kenna, J. G. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1290082 · Cited by 7 · see citing works

Computational methods and applications for quantitative systems pharmacology

Xie, F., & Gu, J. (2019) · Quantitative Biology · doi:10.1007/s40484-018-0161-6 · Cited by 7 · see citing works

Quantitative Systems Toxicology and Drug Development: The DILIsym Experience

Watkins, P. B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2265-0_9 · Cited by 7 · see citing works

Extrapolation of In Vitro Results to Predict Human Toxicity

Das, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804667-8.00007-9 · Cited by 7 · see citing works

Biomarkers of Foods and Nutraceuticals: Applications in Efficacy, Safety, and Toxicity

Gupta, R. C., Srivastava, A., Sinha, A., & Lall, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_50 · Cited by 5 · see citing works

Quantitative Approaches to Accelerate MASH Drug Discovery and Development

Abouelhassan, Y., Tallapaka, S. B., Mehrani, R., Siler, S. Q., Li, Q., Wang, Z., & Trujillo, M. E. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70103 · Cited by 4 · see citing works

Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury

Olubamiwa, A. O., Ma, J., Dehanne, P., Noban, C., Angın, Y., Barberan, O., & Chen, M. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2514537 · Cited by 3 · see citing works

Leading-Edge Approaches for In Vitro Hepatotoxicity Evaluation

LeCluyse, E. L., Norona, L. M., Akingbasote, J. A., Howell, L. S., Woodhead, J. L., Cross, M. J., Roth, A. B., & Goldring, C. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64267-8 · Cited by 2 · see citing works

Mechanisms of Drug‐induced Liver Injury

Watkins, P. B., & Mosedale, M. (2017) · doi:10.1002/9781119251316.ch28 · Cited by 2 · see citing works

INTEGRATED REACTIVE METABOLITE STRATEGIES

Kenna, J. G., & Thompson, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118949689.ch5 · Cited by 1 · see citing works

Mechanism‐Based Experimental Models for the Evaluation of BSEP Inhibition and DILI

Murphy, W. A., Saran, C., Honkakoski, P., & Brouwer, K. L. R. (2021) · doi:10.1002/9781119171003.ch9 · Cited by 1 · see citing works

Mechanistic Modeling of Drug‐Induced Liver Injury (DILI)

Yang, K., Woodhead, J. L., Shoda, L. K. M., Yang, Y., Watkins, P. B., Brouwer, K. L. R., Howell, B. A., & Siler, S. Q. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch09

Systems Pharmacology Modeling

Barton, H. A., M.A., H. J. C. I., & Yoon, M. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622376-00359

Evaluation of New Chemical Entities as Substrates of Liver Transporters in the Pharmaceutical Industry: Response to Regulatory Requirements and Future Steps

Okudaira, N. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.009

In silico prediction of drug-induced liver injury: Quo vadis?

Weng, C., & Leong, M. K. (2019) · Advances in molecular toxicology · doi:10.1016/b978-0-444-64293-6.00002-6

Quantitative Systems Toxicology

Yang, H., & Schaller, S. (2024) · Springer eBooks · doi:10.1007/978-3-030-73317-9_130-1

Quantitative Systems Toxicology

Yang, H., & Schaller, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_130

Pharmacodynamics‐informed Drug Discovery

Chen, E. P. (2025) · Wiley eBooks · doi:10.1002/9781119650263.ch13

Quantitative systems toxicology approach that integrates PBPK and core hepatic metabolism: a case study with valproic acid

Gupta, V., Jo, H., Fisher, C. P., & Kierzek, A. M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1768190

DIGITAL TWIN OF DRUG-INDUCED LIVER INJURY AND SYSTEMIC ADVERSE DRUG REACTIONS IN MASS MEDICATION SCENARIOS: PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS

Kutsenko, V., Ushal, I., Papina, E., Seliverstov, P., Klementeva, A., Yatsuk, Y., Knyazeva, E., & Golikova, L. (2026) · Problems of Biological Medical and Pharmaceutical Chemistry · doi:10.29296/25877313-2026-09-08

In Silico Clinical Trials in Drug Development: Virtual Patients, Applications, and Regulatory Convergence

Balmus, M., Wang, S., Ashton, E. W. G., Barrows, R. K., Monks, M., Ge, Y., Lefebvre, A. L., & Niederer, S. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70492

An Introduction to DILIsym® Software, a Mechanistic Mathematical Representation of Drug-Induced Liver Injury

Battista, C., Howell, B. A., Siler, S. Q., & Watkins, P. B. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_6 · Cited by 9 · see citing works

DILIsym: Quantitative systems toxicology impacting drug development

Watkins, P. B. (2020) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2020.06.003 · Cited by 24 · see citing works

The dili-sim initiative. Integrated systems pharmacology modeling to explain and predict drug hepatotoxicity

Watkins, P. B. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.05.486 · Cited by 3 · see citing works

In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI

Howell, B. A., Yang, Y., Kumar, R., Woodhead, J. L., Harrill, A. H., M.A., H. J. C. I., Andersen, M. E., Siler, S. Q., & Watkins, P. B. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9266-0 · Cited by 105 · see citing works

The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation

Watkins, P. B. (2019) · Clinical and Translational Science · doi:10.1111/cts.12629 · Cited by 60 · see citing works